ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review

Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly diagnosed owing to the emergence of noninvasive imaging and improved awareness. Clinical penetrance of pathogenic alleles is not complete and therefore there is a large cohort of asymptomatic transthyretin variant carriers. Screening strate...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Jan M., Rosenthal, Julie L., Grodin, Justin L., Maurer, Mathew S., Grogan, Martha, Cheng, Richard K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543085/
https://www.ncbi.nlm.nih.gov/pubmed/34729521
http://dx.doi.org/10.1016/j.jaccao.2021.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543085/
https://www.ncbi.nlm.nih.gov/pubmed/34729521
http://dx.doi.org/10.1016/j.jaccao.2021.06.006

Ejemplares similares